266 related articles for article (PubMed ID: 15017227)
1. Fimch antiserum inhibits the adherence of Escherichia coli to cells collected by voided urine specimens of diabetic women.
Meiland R; Geerlings SE; Langermann S; Brouwer EC; Coenjaerts FE; Hoepelman AI
J Urol; 2004 Apr; 171(4):1589-93. PubMed ID: 15017227
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation changes as important factors for the susceptibility to urinary tract infection.
Taganna J; de Boer AR; Wuhrer M; Bouckaert J
Biochem Soc Trans; 2011 Jan; 39(1):349-54. PubMed ID: 21265802
[TBL] [Abstract][Full Text] [Related]
3. Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.
Palaszynski S; Pinkner J; Leath S; Barren P; Auguste CG; Burlein J; Hultgren S; Langermann S
Dev Biol Stand; 1998; 92():117-22. PubMed ID: 9554264
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.
Langermann S; Möllby R; Burlein JE; Palaszynski SR; Auguste CG; DeFusco A; Strouse R; Schenerman MA; Hultgren SJ; Pinkner JS; Winberg J; Guldevall L; Söderhäll M; Ishikawa K; Normark S; Koenig S
J Infect Dis; 2000 Feb; 181(2):774-8. PubMed ID: 10669375
[TBL] [Abstract][Full Text] [Related]
5. Serotype, hemolysin production, and adherence characteristics of strains of Escherichia coli causing urinary tract infection in dogs.
Senior DF; deMan P; Svanborg C
Am J Vet Res; 1992 Apr; 53(4):494-8. PubMed ID: 1350184
[TBL] [Abstract][Full Text] [Related]
6. [Candidate vaccine against urinary tract infections].
Hoepelman IM; Meiland R; Langermann S
Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1860-2. PubMed ID: 11593791
[TBL] [Abstract][Full Text] [Related]
7. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin.
Bouckaert J; Berglund J; Schembri M; De Genst E; Cools L; Wuhrer M; Hung CS; Pinkner J; Slättegård R; Zavialov A; Choudhury D; Langermann S; Hultgren SJ; Wyns L; Klemm P; Oscarson S; Knight SD; De Greve H
Mol Microbiol; 2005 Jan; 55(2):441-55. PubMed ID: 15659162
[TBL] [Abstract][Full Text] [Related]
8. PapG-dependent adherence breaks mucosal inertia and triggers the innate host response.
Bergsten G; Samuelsson M; Wullt B; Leijonhufvud I; Fischer H; Svanborg C
J Infect Dis; 2004 May; 189(9):1734-42. PubMed ID: 15116313
[TBL] [Abstract][Full Text] [Related]
9. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.
Thankavel K; Madison B; Ikeda T; Malaviya R; Shah AH; Arumugam PM; Abraham SN
J Clin Invest; 1997 Sep; 100(5):1123-36. PubMed ID: 9276729
[TBL] [Abstract][Full Text] [Related]
10. Specific residues in the N-terminal domain of FimH stimulate type 1 fimbriae assembly in Escherichia coli following the initial binding of the adhesin to FimD usher.
Munera D; Palomino C; Fernández LA
Mol Microbiol; 2008 Aug; 69(4):911-25. PubMed ID: 18627459
[TBL] [Abstract][Full Text] [Related]
11. Epitopes of the P-fimbrial adhesin of E. coli cause different urinary tract infections.
Roberts JA; Kaack MB; Baskin G; Marklund BI; Normark S
J Urol; 1997 Oct; 158(4):1610-3. PubMed ID: 9302184
[TBL] [Abstract][Full Text] [Related]
12. [Construction and characterization of type I fimbriae fimH deletion mutant from avian pathogenic Escherichia coli].
He S; Yuan Z; Zhu G
Wei Sheng Wu Xue Bao; 2008 Feb; 48(2):252-6. PubMed ID: 18438011
[TBL] [Abstract][Full Text] [Related]
13. Genetic engineering of avian pathogenic E. coli to study the functions of FimH adhesin.
Musa HH; He SF; Wu SL; Zhu CH; Liu ZH; Zhang ZN; Raj VS; Gu RX; Zhu GQ
Indian J Exp Biol; 2009 Nov; 47(11):916-20. PubMed ID: 20099466
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition.
Roos V; Nielsen EM; Klemm P
FEMS Microbiol Lett; 2006 Sep; 262(1):22-30. PubMed ID: 16907735
[TBL] [Abstract][Full Text] [Related]
15. Development of an aggregation assay to screen FimH antagonists.
Abgottspon D; Rölli G; Hosch L; Steinhuber A; Jiang X; Schwardt O; Cutting B; Smiesko M; Jenal U; Ernst B; Trampuz A
J Microbiol Methods; 2010 Sep; 82(3):249-55. PubMed ID: 20620174
[TBL] [Abstract][Full Text] [Related]
16. Increased tracheal colonization in chickens without impairing pathogenic properties of avian pathogenic Escherichia coli MT78 with a fimH deletion.
Arné P; Marc D; Brée A; Schouler C; Dho-Moulin M
Avian Dis; 2000; 44(2):343-55. PubMed ID: 10879915
[TBL] [Abstract][Full Text] [Related]
17. Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli FimH adhesin.
Weissman SJ; Beskhlebnaya V; Chesnokova V; Chattopadhyay S; Stamm WE; Hooton TM; Sokurenko EV
Infect Immun; 2007 Jul; 75(7):3548-55. PubMed ID: 17502398
[TBL] [Abstract][Full Text] [Related]
18. The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes.
Bouckaert J; Mackenzie J; de Paz JL; Chipwaza B; Choudhury D; Zavialov A; Mannerstedt K; Anderson J; Piérard D; Wyns L; Seeberger PH; Oscarson S; De Greve H; Knight SD
Mol Microbiol; 2006 Sep; 61(6):1556-68. PubMed ID: 16930149
[TBL] [Abstract][Full Text] [Related]
19. Decreased predominance of papG class II allele in Escherichia coli strains isolated from adults with acute pyelonephritis and urinary tract abnormalities.
Tseng CC; Huang JJ; Ko WC; Yan JJ; Wu JJ
J Urol; 2001 Nov; 166(5):1643-6. PubMed ID: 11586193
[TBL] [Abstract][Full Text] [Related]
20. Receptors for Escherichia coli adhesins in the genitourinary tract in a non-human primate.
Ishikawa K; Sundelin B; Möllby R; Normark S; Winberg J
Scand J Urol Nephrol; 2004; 38(1):3-14. PubMed ID: 15204420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
